Search Results - "Szumski, Annette E."

Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies by Baraliakos, Xenofon, Szumski, Annette E., Kwok, Kenneth K., Vlahos, Bonnie, Borlenghi, Cecilia E.

“…Introduction Short-term placebo (PBO)- or active-controlled clinical studies have demonstrated that etanercept (ETN) is effective and well tolerated in…”
Get full text

Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial by Schneeberger, Emilce E., Citera, Gustavo, de Leon, Dario Ponce, Szumski, Annette E., Kwok, Kenneth, Cutri, Mariel, Dougados, Maxime

“…OBJECTIVETo compare the Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) against the Ankylosing Spondylitis Disease Activity Score (ASDAS) for…”
Get full text

Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies by Schneeberger, Emilce E., Citera, Gustavo, Nash, Peter, Smolen, Josef S., Mease, Philip J., Soriano, Enrique R., Helling, Claudia, Szumski, Annette E., Mundayat, Rajiv, de León, Darío Ponce

“…•DAPSA-REM/LDA and VLDA/MDA were compared in tofacitinib-treated patients with PsA.•Agreement for DAPSA-REM with VLDA, and DAPSA-LDA with MDA, was moderate…”
Get full text

Clinical, Radiologic, and Functional Outcomes Following Methotrexate Withdrawal in Etanercept-Treated Patients with Active Early Rheumatoid Arthritis: A Subanalysis of COMET Year 2 by Week 52 DAS28 Status by Emery, Paul, Breedveld, Ferdinand, Campos-Alberto, Eduardo, Szumski, Annette E., Hirose, Tomohiro

Get full text